P&G stock drops nearly 1% as TD Cowen downgrades; investors weigh tariffs and a new Wonderbelly buy
28 January 2026
2 mins read

P&G stock drops nearly 1% as TD Cowen downgrades; investors weigh tariffs and a new Wonderbelly buy

New York, Jan 28, 2026, 3:02 PM EST — Regular session

  • Procter & Gamble shares dropped roughly 1% in afternoon trading, following a wider slump across consumer staples.
  • TD Cowen downgraded P&G to “Hold,” citing a sluggish recovery driven by weakening pricing power and increased promotions.
  • P&G spotlights a Wonderbelly buy and a fresh Crest toothpaste rollout, but rate shifts steal the spotlight.

Procter & Gamble shares dropped almost 1% Wednesday afternoon, slipping alongside broader consumer staples weakness and a new brokerage downgrade weighing on the stock. It hit a low of $146.88 before settling down 1.0% at $146.89.

The pullback is significant since P&G is a textbook “defensive” stock — known for steady demand, strong brands, and consistent cash payouts. Investors tend to favor it when growth wobbles. But as Treasury yields climb, these dividend-focused shares often lose some shine, with bonds providing tougher competition.

The timing coincides with a fierce debate over pricing power and how fast consumers shift to cheaper options when discounts pop up. For P&G, this strikes at the core — diapers, detergent, and paper products.

TD Cowen cut its rating on the Tide and Pampers maker to “Hold” from “Buy,” but raised the price target to $156. The firm now expects the recovery to be slower than anticipated, with muted pricing and a heavier reliance on promotions. It projects roughly 2% “organic” sales growth—excluding currency effects and acquisitions—for fiscal years 2026 and 2027. TD Cowen also noted recent share losses and intensified promotional activity in several categories. 1

The company is pushing to expand its health segment amid efforts to boost growth in its main aisles. On Jan. 26, P&G announced in a blog post that Wonderbelly — a “free-from” digestive wellness brand — has been added to its Personal Health Care lineup, joining names like Metamucil and Pepto-Bismol. “Bringing Wonderbelly into the PHC digestive wellness portfolio complements our existing brands,” said Phil McWaters, senior vice president at P&G Personal Health Care. 2

Crest, a major player in P&G’s oral-care lineup, launched a new “Clean Breath” toothpaste this week. The product targets odor-causing bacteria and is designed for daily use. “We know consumers are frustrated by having to continually fight against bad breath,” said Dr. Svetlana Farrell, Oral Care, North America at Procter & Gamble, in the company’s announcement. 3

A regulatory filing provided fresh insight for investors. According to a Form 4, Chief Brand Officer Marc S. Pritchard exercised options and offloaded 95,903 shares, with the transaction logged at a weighted average price near $151.15 each. 4

Tariffs continue to weigh on margins and pricing strategies. Reuters reported this week that P&G has bumped prices in the U.S. by about 2% to 2.5% to counter tariff expenses and sluggish sales, while posting its fifth consecutive quarterly margin decline. “Most consumers are still mad about the level of current prices and won’t take kindly to further hikes,” said Brian Jacobsen, chief economic strategist at Annex Wealth Management. 5

The macro environment offered little relief. On Wednesday, the Federal Reserve kept rates unchanged and highlighted “elevated” inflation in its latest policy update, putting bond yields under the spotlight for sectors reliant on steady cash flow and dividends. 6

In the consumer sector, investors are weighing “resilient demand” against “more discounting.” Kimberly-Clark, a key competitor in diapers and tissues, posted better-than-expected profits just a day earlier, driven by cost reductions and steady essentials demand — highlighting how execution and price/mix currently play a crucial role in staples. 7

The downside risk for P&G is well-known: if promotions ramp up to hold shelf space and volume, margins could shrink fast—especially if tariff expenses or other input costs remain high. A weaker consumer, especially among price-conscious families, would only make that squeeze tougher.

Traders will be eyeing broader market moves after hours, with Microsoft and Meta set to report earnings Wednesday. Alphabet and Amazon follow next week. They’ll also watch whether staples can maintain prices without sacrificing much volume. 8

Stock Market Today

Verizon stock price snaps 7-day run as consumer chief exit sharpens focus on turnaround

Verizon stock price snaps 7-day run as consumer chief exit sharpens focus on turnaround

7 February 2026
New York, February 6, 2026, 21:06 EST — Market closed. Verizon Communications Inc shares fell 1.7% on Friday to $46.31, snapping a seven-day streak of gains and pulling back from a one-year high set a day earlier. 1 The dip followed a sharp late-January run-up that pushed the stock back into the mid-$40s. Verizon has climbed about 16% since its January 29 close of $39.81, leaving little room for stumbles as traders position for the week ahead. 2 The latest wrinkle is a leadership change at Verizon’s consumer business, the latest sign of an overhaul under CEO Dan Schulman. Consumer
Cisco stock jumps 3% near $85 as UBS sticks with Buy ahead of Feb. 11 earnings

Cisco stock jumps 3% near $85 as UBS sticks with Buy ahead of Feb. 11 earnings

7 February 2026
Cisco shares rose 3% to $84.82 Friday, nearing $85 ahead of fiscal Q2 results due Feb. 11. UBS maintained a Buy rating and $90 target, citing strong product order growth and data-center demand. Investors are watching AI-related spending and U.S. economic data that could affect rates. Peers Fortinet, CrowdStrike, and Palo Alto Networks also gained.
Coherent stock whiplash: COHR jumps after earnings drop — what to watch next week

Coherent stock whiplash: COHR jumps after earnings drop — what to watch next week

7 February 2026
Coherent Corp shares jumped 8.8% to $227.68 Friday, rebounding after a two-day slide following its quarterly results. The company reported December-quarter revenue of $1.69 billion and non-GAAP earnings of $1.29 a share, with datacenter and communications driving 72% of sales. Barclays, Stifel, and JPMorgan raised price targets to $235–$245. FMR LLC disclosed a 15% stake as of Dec. 31.
Fed holds rates, S&P 500 flirts with 7,000 as AI bets and dollar swings collide
Previous Story

Fed holds rates, S&P 500 flirts with 7,000 as AI bets and dollar swings collide

Bloom Energy stock jumps nearly 10% as Barclays starts coverage ahead of earnings
Next Story

Bloom Energy stock jumps nearly 10% as Barclays starts coverage ahead of earnings

Go toTop